EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulating Endoplasmic Reticulum Chaperones and Mutant Protein Degradation in GABRG2(Q390X) Associated with Genetic Epilepsy with Febrile Seizures Plus and Dravet Syndrome

Sarah Poliquin, Gerald Nwosu iD, Karishma Randhave, Wangzhen Shen, Carson Flamm, Jing-Qiong Kang iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25094601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sarah Poliquin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Graduate Program, Vanderbilt University, Nashville, TN 37232, USA. Hauptthemen laut MEDLINE: Epilepsies, Myoclonic, Receptors, GABA-A, Endoplasmic Reticulum, Proteolysis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NINDS NIH HHS, National Institute of Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A significant number of patients with genetic epilepsy do not obtain seizure freedom, despite developments in new antiseizure drugs, suggesting a need for novel therapeutic approaches. Many genetic epilepsies are associated with misfolded mutant proteins, including GABRG2(Q390X)-associated Dravet syndrome, which we have previously shown to result in intracellular accumulation of mutant GABAA receptor γ2(Q390X) subunit protein. Thus, a potentially promising therapeutic approach is modulation of proteostasis, such as increasing endoplasmic reticulum (ER)-associated degradation (ERAD). To that end, we have here identified an ERAD-associated E3 ubiquitin ligase, HRD1, among other ubiquitin ligases, as a strong modulator of wildtype and mutant γ2 subunit expression. Overexpressing HRD1 dose-dependently reduced the γ2(Q390X) subunit. Additionally, we show that zonisamide (ZNS)—an antiseizure drug reported to upregulate HRD1—reduces seizures in the Gabrg2+/Q390X mouse. We propose that a possible mechanism for this effect is a partial rescue of surface trafficking of GABAA receptors, which are otherwise sequestered in the ER due to the dominant-negative effect of the γ2(Q390X) subunit. Furthermore, this partial rescue was not due to changes in ER chaperones BiP and calnexin, as total expression of these chaperones was unchanged in γ2(Q390X) models. Our results here suggest that leveraging the endogenous ERAD pathway may present a potential method to degrade neurotoxic mutant proteins like the γ2(Q390X) subunit. We also demonstrate a pharmacological means of regulating proteostasis, as ZNS alters protein trafficking, providing further support for the use of proteostasis regulators for the treatment of genetic epilepsies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsies, MyoclonicReceptors, GABA-AEndoplasmic ReticulumProteolysisAnimalsMiceHumansSeizures, FebrileEndoplasmic Reticulum-Associated DegradationUbiquitin-Protein LigasesMolecular ChaperonesMutationHEK293 CellsEndoplasmic Reticulum Chaperone BiP

Stichwörter der Autor:innen

Dravet syndromeE3 ubiquitin ligaseGABAA receptorendoplasmic-reticulum-associated protein degradation (ERAD)epilepsyintracellular traffickingproteostasis

Substanzen

Receptors, GABA-AUbiquitin-Protein LigasesMolecular ChaperonesGABRG2 protein, humanSYVN1 protein, humanGabrg2 protein, mouseEndoplasmic Reticulum Chaperone BiP

Autor:innen und Institutionen

  • Neuroscience Graduate Program, Vanderbilt University, Nashville, TN 37232, USA.
  • Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37232, USA.
  • Department of Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN 37208, USA.
  • Department of Neurology, Vanderbilt University Medical Center, 465 21st Ave South, Nashville, TN 37232, USA.
  • Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
  • Vanderbilt Kennedy Center of Human Development, Vanderbilt University, Nashville, TN 37232, USA.

ORCID-Profile: Gerald Nwosu, Jing-Qiong Kang

Förderung

  • NICHD NIH HHS
  • NINDS NIH HHS
  • National Institute of Health Sciences
  • ational Institute of Neurological Disease and Stroke (NINDS)

Zitieren

APA

Poliquin, S., Nwosu, G., Randhave, K., Shen, W., Flamm, C., & Kang, J. Q. (2024). Modulating Endoplasmic Reticulum Chaperones and Mutant Protein Degradation in GABRG2(Q390X) Associated with Genetic Epilepsy with Febrile Seizures Plus and Dravet Syndrome. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094601

Vancouver

Poliquin S, Nwosu G, Randhave K, Shen W, Flamm C, Kang JQ. Modulating Endoplasmic Reticulum Chaperones and Mutant Protein Degradation in GABRG2(Q390X) Associated with Genetic Epilepsy with Febrile Seizures Plus and Dravet Syndrome. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094601

BibTeX
@article{Poliquin2024,
  author = {Poliquin, Sarah and Nwosu, Gerald and Randhave, Karishma and Shen, Wangzhen and Flamm, Carson and Kang, Jing-Qiong},
  title = {Modulating Endoplasmic Reticulum Chaperones and Mutant Protein Degradation in GABRG2(Q390X) Associated with Genetic Epilepsy with Febrile Seizures Plus and Dravet Syndrome},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25094601}
}
Kostenlos starten →